MedTrace Logo

Cardiac Dysfunction in Critically Ill Covid-19 Patients

NCT06197256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2024-01-09

No results posted yet for this study

Summary

We conducted an observation sub-study of the prospective randomized controlled trial "High Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure", in which we analysed the echocardiographic data collected both at baseline when patients where included and 3-5 days later for followup.

Conditions

  • COVID-19
  • ARDS, Human
  • Cardiac Failure
  • Right Ventricular Dysfunction
  • Left Ventricular Dysfunction
  • Pulmonary Hypertension

Sponsors & Collaborators

Principal Investigators

  • Daniel Törnberg, MD PhD · KI DS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-07
Primary Completion
2021-02-11
Completion
2021-02-11

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06197256 on ClinicalTrials.gov